The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival

Cancer Policy

Cancer patients could be exempted from Medicaid work requirements if they prove they are “medically frail”

Richard Pazdur joins Friends board

Protect the integrity of USPSTF, patient and provider groups urge in letter to Kennedy

FDA issues a warning to retailers selling illegal tobacco products that resemble everyday items

FDA advisory panel votes to recommend updated 2026-2027 formula for COVID-19 vaccines

Pam Bondi diagnosed with thyroid cancer

Clinical Roundup

GRAIL reports full results from NHS-Galleri trial at ASCO

Teclistamab improves outcomes in relapsed MM, phase III trial finds

Adding immunotherapy to radiation improves disease-free survival in localized prostate cancer, phase III trial finds

Camizestrant combination delayed time to first progression by 55% in patients with advanced HR+ breast cancer with ESR1 tumor mutation

OST-HER2 achieves 2.5-year OS in fully resected pulmonary metastatic osteosarcoma, phase IIb trial finds

Catheter with specialized nanosensors could enable earlier detection of bladder cancer, MIT study finds

In The Clinic

When CAM is added to standard therapies, survival rates drop, observational study finds

Trials & Tribulations
Latest Issue
Read the latest issue
Read the latest issue
DOWNLOAD THE PDF
UPCOMING EVENTS
Jun 2026
25
MASCC/ISOO 2026 Annual Meeting
Sep 2026
18
NCCN 2026 Annual Congress: Hematologic Malignancies™️
View All Events

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account